Top 10 Prescription Drugs 2021

-

 

This year Xarelto, a drug made by Bayer and J & J, was in 10th position. Till now, this Factor Xa Inhibitor pharmacological product sales was of worth $7605 million.

BTK inhibitor pharmacological class product – Imbruvica ranked 9th position. AbbVie, a maker of this drug, made $7607 million from this drug.

HIV INSTI/ NRTI/ NRTI pharmacological class drug –Biktarvy held 8th position in 2021. Gilead Sciences made around $8418 million worth of sales from this product.

J & J and Mitsubishi Chemical Anti – IL12/IL23 mAb pharmacological class product named Stelara ranked 7th positions. This year, a totals sale was around $8445 million.

Opdivo, an Anti-PD1mAb product, was in 6th position. Bristol Myers Squibb and Ono Pharm were the makers of this product. With this drug, both companies achieved sales of around $8759 million at this moment.

Eylea, an Anti-VEGF mAb pharmacological class product, had secured 5th position. This drug was the combined effort of Regeneron, Bayer and Santel Pharmaceutical. This year from this drug, total sales of $8872 million it brought.

Eliquis, a Factor Xa Inhibitor product, ranked 4th position. Bristol-Myers, Bayer-Squibb and Pfizer were the producers of this drug. $10546 million of sales were made from this drug till now.

An Immunomodulator pharmacological class product named Revlimid held 3rd rank. Bristol-Myers and Bayer-Squibb were the drug makers and around $12710 million of sales this drug brought.

Merck’s Keytruda – Anti-PD 1 mAb product was in 2nd rank. In 2021, the total sale was $16825 million as of now.

Humira, an Anti-TNF mAb product of AbbVie/Eisai, ranked 1st position. Till now, the total sale was $19963 million.

 

 

 

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: